Analyst Ratings for Bolt Biotherapeutics, Inc. (BOLT)
BOLT Rating Summary
BOLT Price Target Summary
- Highest: $22.00 (Rodman & Renshaw)
- Lowest: $6.00 (Leerink)
- Average: $11.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$11.67 (+186.7%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$11.67 (+186.7%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
22.00 (N/A) |
5.28 (4.07) |
-22.92% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Hold (N/A) |
N/A (N/A) |
4.29 (4.07) |
-5.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
